Founder, Chief Executive Officer and Chief Scientist, Zensun (Shanghai) Sci. &Tech. Co., Ltd.
Dr. Mingdong Zhou Founded Zensun (Shanghai) Sci. &Tech. Co., Ltd. in 2000 and serves as its Chief Executive Officer and Chief Scientist. In 1996, Dr. Zhou joined the Victor Chang Cardiac Research Institute, Sydney, Australia, where he headed the Cell Signaling Laboratory. During this time he discovered important effects of neuregulins in improving myocardial cell structure and function, as well as the fact that ErbB2/ErbB3 hetero-dimerization is essential for tumor development.